Daewoong's Doctor Bearse fared well in first quarter

Published: 2004-07-30 06:58:00

Updated: 2004-07-30 06:58:00

Daewoong Pharm said its OTC digestive, Doctor Bearse, surpassed 3.5 billion won in sales for the first three months of 2004, recapturing first rank to Handok Pharm's Festal Plus.

The company attributed the surge of Doctor Bearse, an up-date version of Bearse, to aggressive advertisement campai...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK